L‐Selectin Expression is Influenced by Phosphatase Activity in Chronic Lymphocytic Leukemia

Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous Leukemia

(2017) Sieghart Sopper et al.   JOURNAL OF CLINICAL ONCOLOGY

CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma

(2016) Casey E. Gooden et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A

(2015) F. Zonta et al.   BLOOD

L-selectin controls trafficking of chronic lymphocytic leukemia cells in lymph node high endothelial venules in vivo

(2015) F. Lafouresse et al.   BLOOD

Inhibition of protein phosphatase-1 and -2A decreases the chemosensitivity of leukemic cells to chemotherapeutic drugs

(2015) Dóra Dedinszki et al.   CELLULAR SIGNALLING

Treatment with Ibrutinib Inhibits BTK- and VLA-4-Dependent Adhesion of Chronic Lymphocytic Leukemia Cells In Vivo

(2015) S. E. M. Herman et al.   CLINICAL CANCER RESEARCH

Neutrophils recruit and activate human endothelial colony-forming cells at the site of vessel injury via P-selectin glycoprotein ligand-1 and L-selectin

(2014) L. Hubert et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The Basic Biology of PP2A in Hematologic Cells and Malignancies

(2014) Dorien Haesen et al.   Frontiers in Oncology

The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia

(2013) Gabriele Brachtl et al.   ANNALS OF HEMATOLOGY

CD62L as a Therapeutic Target in Chronic Lymphocytic Leukemia

(2013) M. Burgess et al.   CLINICAL CANCER RESEARCH

SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target

(2011) D. J. Christensen et al.   BLOOD

The cytoplasmic domains of TNFα-converting enzyme (TACE/ADAM17) and L-selectin are regulated differently by p38 MAPK and PKC to promote ectodomain shedding

(2010) David J. Killock et al.   BIOCHEMICAL JOURNAL

Chronic lymphocytic leukaemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing

(2010) Andy C. Rawstron et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Down-regulation of CXCR4 and CD62L in Chronic Lymphocytic Leukemia Cells Is Triggered by B-Cell Receptor Ligation and Associated with Progressive Disease

(2009) A. Vlad et al.   CANCER RESEARCH

Regulation of Mature ADAM17 by Redox Agents for L-Selectin Shedding

(2009) Y. Wang et al.   JOURNAL OF IMMUNOLOGY